Skip to Content
You are currently on the new version of our website. Access the old version .
  • Article
  • Open Access

19 February 2021

15 Pages

Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells

,
,
,
,
and
1
Department of Biochemistry and Medical Chemistry, University of Pécs Medical School, 7624 Pécs, Hungary
2
Szentagothai Research Centre, University of Pécs, 7624 Pécs, Hungary
3
Nuclear-Mitochondrial Interactions Research Group, Hungarian Academy of Sciences, 1052 Budapest, Hungary
*
Author to whom correspondence should be addressed.

Abstract

Triple-negative breast cancer (TNBC) has a poor prognosis as the therapy has several limitations, most importantly, treatment resistance. In this study we examined the different responses of triple-negative breast cancer line MDA-MB-231 and hormone receptor-positive breast cancer line MCF7 to a combined treatment including olaparib, a poly-(ADP ribose) polymerase (PARP) inhibitor, oxaliplatin, a third-generation platinum compound and LY294002, an Akt pathway inhibitor. We applied the drugs in a single, therapeutically relevant concentration individually and in all possible combinations, and we assessed the viability, type of cell death, reactive oxygen species production, cell-cycle phases, colony formation and invasive growth. In agreement with the literature, the MDA-MB-231 cells were more treatment resistant than the MCF7 cells. However, and in contrast with the findings of others, we detected no synergistic effect between olaparib and oxaliplatin, and we found that the Akt pathway inhibitor augmented the cytostatic properties of the platinum compound and/or prevented the cytoprotective effects of PARP inhibition. Our results suggest that, at therapeutically relevant concentrations, the cytotoxicity of the platinum compound dominated over that of the PARP inhibitor and the PI3K inhibitor, even though a regression-based model could have indicated an overall synergy at lower and/or higher concentrations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.